Tamara A. Sussman

566 total citations
31 papers, 250 citations indexed

About

Tamara A. Sussman is a scholar working on Oncology, Internal Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tamara A. Sussman has authored 31 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 10 papers in Internal Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tamara A. Sussman's work include Cancer Immunotherapy and Biomarkers (11 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and CAR-T cell therapy research (8 papers). Tamara A. Sussman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and CAR-T cell therapy research (8 papers). Tamara A. Sussman collaborates with scholars based in United States, India and Canada. Tamara A. Sussman's co-authors include Pauline Funchain, Alok A. Khorana, Keith R. McCrae, Brian P. Hobbs, Hong Li, Megan Kruse, Holly L. Thacker, Jame Abraham, Arun D. Singh and Brian Gastman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tamara A. Sussman

31 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tamara A. Sussman United States	9	146	80	43	37	36	31	250
Jodi V. Mones United States	8	90 0.6×	84 1.1×	25 0.6×	61 1.6×	39 1.1×	21	283
Jaime Garcı́a-Chávez Mexico	9	33 0.2×	20 0.3×	37 0.9×	18 0.5×	43 1.2×	32	311
Granada Perea Spain	8	74 0.5×	21 0.3×	91 2.1×	46 1.2×	12 0.3×	12	278
Sunamchok Srijaipracharoen Thailand	9	226 1.5×	8 0.1×	17 0.4×	15 0.4×	31 0.9×	20	373
Rowan G. Doig Australia	7	43 0.3×	98 1.2×	13 0.3×	69 1.9×	17 0.5×	11	297
Minodora Onisâi Romania	10	33 0.2×	7 0.1×	46 1.1×	20 0.5×	24 0.7×	40	266
Karol Nowak Poland	11	38 0.3×	32 0.4×	5 0.1×	126 3.4×	20 0.6×	39	296
Jinghe Lang China	11	60 0.4×	15 0.2×	68 1.6×	6 0.2×	5 0.1×	24	307
Anna Christoforidou Greece	10	52 0.4×	15 0.2×	15 0.3×	25 0.7×	39 1.1×	29	227
Emily Prendergast United States	10	78 0.5×	31 0.4×	37 0.9×	9 0.2×	25 0.7×	29	326

Countries citing papers authored by Tamara A. Sussman

Since Specialization

Citations

This map shows the geographic impact of Tamara A. Sussman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara A. Sussman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara A. Sussman more than expected).

Fields of papers citing papers by Tamara A. Sussman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara A. Sussman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara A. Sussman. The network helps show where Tamara A. Sussman may publish in the future.

Co-authorship network of co-authors of Tamara A. Sussman

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara A. Sussman. A scholar is included among the top collaborators of Tamara A. Sussman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara A. Sussman. Tamara A. Sussman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clark, Patricia, Shauna R. Campbell, N.M. Woody, et al.. (2025). Highly-multiplex detection of plasma cell-free human papillomavirus-16 DNA in oropharyngeal carcinoma. Journal of Clinical Virology. 176. 105760–105760. 1 indexed citations

Fan, Cong, J.L. Geiger, Tamara A. Sussman, et al.. (2024). Plasma circulating tumor DNA in patients with cutaneous squamous cell carcinoma: Initial experience.. Journal of Clinical Oncology. 42(16_suppl). e15034–e15034. 1 indexed citations

Sussman, Tamara A. & Patrick A. Ott. (2024). Adjuvant immunotherapy for melanoma patients: progress and opportunities. ESMO Open. 9(5). 102962–102962. 8 indexed citations

Giobbie‐Hurder, Anita, Miklos C. Fogarasi, Patrick A. Ott, et al.. (2024). Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab. Journal for ImmunoTherapy of Cancer. 12(8). e009061–e009061. 5 indexed citations

Fan, Cong, Jacob A. Miller, Shauna R. Campbell, et al.. (2024). Primary immunotherapy monotherapy (PRIMO) in locally advanced cutaneous squamous cell carcinoma.. Journal of Clinical Oncology. 42(16_suppl). 9585–9585. 1 indexed citations

Stewart, Murray, Teodora Kuzmanovic, Shauna R. Campbell, et al.. (2024). Can Circulating Tumor DNA be Utilized as a Marker to Guide High-Risk Head and Neck Squamous Cell Patients Treatment?. International Journal of Radiation Oncology*Biology*Physics. 118(5). e33–e34. 1 indexed citations

Schuster, James, C.A. Reddy, Alok A. Khorana, et al.. (2023). Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 22(2). 92–97. 1 indexed citations

Sussman, Tamara A., Elizabeth I. Buchbinder, Patrick A. Ott, et al.. (2022). Thromboembolism (TE) and association with survival in patients (pts) with melanoma receiving chemo– or immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). 12082–12082. 1 indexed citations

Gupta, Shilpa, C.A. Reddy, Dana E. Angelini, et al.. (2022). Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors. Targeted Oncology. 17(5). 563–569. 9 indexed citations

10.

Gupta, Shilpa, C.A. Reddy, Dana E. Angelini, et al.. (2021). Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy. Targeted Oncology. 16(6). 813–821. 9 indexed citations

11.

Sussman, Tamara A., et al.. (2021). Treatment of Patients with Prediabetes in a Primary Care Setting 2011–2018: an Observational Study. Journal of General Internal Medicine. 36(4). 923–929. 13 indexed citations

12.

Sussman, Tamara A., Wei Wei, Pauline Funchain, & Brian Gastman. (2021). Outcomes of stage IV melanoma in the era of immunotherapy (IO): A National Cancer Database (NCDB) analysis.. Journal of Clinical Oncology. 39(15_suppl). e21520–e21520. 2 indexed citations

13.

Sussman, Tamara A., et al.. (2020). Venous thromboembolism (VTE) in melanoma patients (pts) on immunotherapy (IO).. Journal of Clinical Oncology. 38(5_suppl). 94–94. 6 indexed citations

14.

Sussman, Tamara A., Pauline Funchain, & Arun D. Singh. (2020). Clinical Trials in Metastatic Uveal Melanoma: Current Status. Ocular Oncology and Pathology. 6(6). 381–387. 17 indexed citations

15.

Sussman, Tamara A., Wei Wei, Pauline Funchain, & Brian Gastman. (2020). 224 Outcomes of stage IV melanoma in the era of immunotherapy: a national cancer database (NCDB) analysis. SHILAP Revista de lepidopterología. A133.2–A134. 5 indexed citations

16.

Sussman, Tamara A., Wei Wei, Brian P. Hobbs, et al.. (2020). A phase II trial of nivolumab in combination with talazoparib in unresectable or metastatic melanoma patients with mutations in BRCA or BRCAness.. Journal of Clinical Oncology. 38(15_suppl). TPS10082–TPS10082. 3 indexed citations

17.

Sussman, Tamara A., Mohamed E. Abazeed, Keith R. McCrae, & Alok A. Khorana. (2019). RNA expression and risk of venous thromboembolism in lung cancer. Research and Practice in Thrombosis and Haemostasis. 4(1). 117–123. 12 indexed citations

18.

Sussman, Tamara A., Megan Kruse, Holly L. Thacker, & Jame Abraham. (2019). Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy. Journal of Oncology Practice. 15(7). 363–370. 41 indexed citations

19.

Sussman, Tamara A., et al.. (2018). Abstract P5-21-26: T-DM1 activity in metastatic HER2-positive breast cancer patients who have received prior trastuzumab and pertuzumab: NSABP B-005. Cancer Research. 78(4_Supplement). P5–21. 1 indexed citations

20.

Sussman, Tamara A., Mohamed E. Abazeed, Keith R. McCrae, & Alok A. Khorana. (2017). RNA Sequencing Approaches to Identify Novel Biomarkers for Venous Thromboembolism (VTE) in Lung Cancer. Blood. 130. 554–554. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact